LifeSciences
-
Financial
Integra LifeSciences to Acquire Derma Sciences Inc. and Announces Preliminary Fourth Quarter and Full Year 2016 Financial Results and 2017 Outlook
PLAINSBORO, N.J., Jan. 10, 2017 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (Nasdaq:IART), a global leader in medical technology, announced…
Read More » -
Financial
Integra LifeSciences Announces Approval of Two-for-One Stock Split
PLAINSBORO, N.J., Dec. 22, 2016 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that its stockholders approved a…
Read More » -
Financial
Integra LifeSciences Announces Expansion and Extension of Credit Facility to $1.5 Billion
PLAINSBORO, N.J., Dec. 07, 2016 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation(NASDAQ:IART) today announced that it has increased its credit…
Read More » -
Extremities
Integra LifeSciences Announces Key Executive Appointments
PLAINSBORO, N.J., Dec. 05, 2016 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced key executive appointments effective December…
Read More » -
Financial
Integra LifeSciences Announces Plans for a Two-For-One Stock Split and Increase in Authorized Shares
PLAINSBORO, N.J., Oct. 27, 2016 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that its Board of Directors…
Read More » -
Biologics
Integra LifeSciences Organizes Hands-on Wound Workshop on Best Practices for Omnigraft® Dermal Regeneration Matrix and PriMatrix® Dermal Repair Scaffold at Symposium on Advanced Wound Care (SAWC) Fall Meeting
PLAINSBORO, N.J., Oct. 17, 2016 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (Nasdaq:IART) recently organized a hands-on regenerative wound management workshop…
Read More » -
Extremities
Integra LifeSciences Announces First Clinical Uses of Cadence™ Total Ankle System in Europe
Plainsboro, N.J., Sept. 20, 2016 (Globe Newswire) (NASDAQ:IART), a leading global medical technology company, today announced that the first three…
Read More » -
Extremities
Integra LifeSciences Announces that Omnigraft™ Dermal Regeneration Matrix was Recognized as a Top Ten Innovation by Podiatry Today
PLAINSBORO, N.J., Aug. 01, 2016 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today…
Read More » -
Financial
Integra LifeSciences Reports Second Quarter 2016 Financial Results
PLAINSBORO, N.J., July 28, 2016 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (NASDAQ:IART) today reported its financial results for the…
Read More » -
Recon
Integra LifeSciences launches Integra® Fin-Lock™ Glenoid for the Titan™ Modular Shoulder System
PLAINSBORO, N.J., May 23, 2016 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (Nasdaq:IART), a leading global medical technology company, today…
Read More » -
Hospitals
Integra LifeSciences Receives FDA Approval for Integra® Omnigraft™ Dermal Regeneration Matrix, Clearing the Way for Commercial Release
PLAINSBORO, N.J., May 11, 2016 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today…
Read More » -
Hospitals
Integra LifeSciences Provides Update for Omnigraft™ Commercialization Plans, Including Expectations for an Earlier Launch
PLAINSBORO, N.J., April 27, 2016 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today…
Read More » -
Financial
Integra LifeSciences Reports First Quarter 2016 Financial Results
PLAINSBORO, N.J., April 27, 2016 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (NASDAQ:IART) today reported its financial results for the…
Read More » -
Extremities
Integra LifeSciences Announces Initial Clinical Use of the Cadence™ Total Ankle System in the United States
PLAINSBORO, N.J., April 26, 2016 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today…
Read More »